Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human CLN6 Protein, N-GST & C-His

Catalog #:   YHK83801 Specific References (48) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q9NWW5
Protein length: Asp131-Glu174
Overview

Catalog No.

YHK83801

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Asp131-Glu174

Predicted molecular weight

33.49 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q9NWW5

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Ceroid-lipofuscinosis neuronal protein 6, CLN6, Protein CLN6

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human CLN6 protein
References

Expanded Phenotype of the Cln6nclf Mouse Model., PMID:40358187

Genetic Reasons for Phenotypic Diversity in Neuronal Ceroid Lipofuscinoses and High-Resolution Imaging as a Marker of Retinal Disease., PMID:40206986

2024 Scholars' Research Symposium Abstract: Sex-Split Analysis of Pathology and Motor-Behavioral Outcomes in a Mouse Model Of CLN8-Batten Disease., PMID:39820909

CLN6-related continuum phenotype caused by aberrant splicing., PMID:39718800

Genetic spectrum of neuronal ceroid lipofuscinosis & its genotype-phenotype correlation -A single centre experience of 56 cases., PMID:39675099

Pro-cathepsin D prevents aberrant protein aggregation dependent on endoplasmic reticulum protein CLN6., PMID:39032464

Neuronal Ceroid Lipofuscinosis in a Mixed-Breed Dog with a Splice Site Variant in CLN6., PMID:38927597

Mutations in CLCN6 as a Novel Genetic Cause of Neuronal Ceroid Lipofuscinosis in Patients and a Murine Model., PMID:38877824

Neuronal ceroid lipofuscinosis in a Schapendoes dog is caused by a missense variant in CLN6., PMID:38866396

Phenotypic/Genotypic Profile of Children with Neuronal Ceroid Lipofuscinosis in Southern Brazil., PMID:38857616

A novel homozygous CLN6 Tyr142Cys variant in a nonconsanguineous family with Kufs disease., PMID:38771523

Clinical and Molecular Characteristics of Neuronal Ceroid Lipofuscinosis in Saudi Arabia., PMID:38653183

Natural History of Neuronal Ceroid Lipofuscinosis Type 6, Late Infantile Disease., PMID:38531163

Whole exome sequencing identifies variable expressivity of CLN6 variants in Progressive myoclonic epilepsy affected families., PMID:38382230

Cellular Modeling of CLN6 with IPSC-derived Neurons and Glia., PMID:38352418

Developmental Skills and Neurorehabilitation for Children With Batten Disease: A Retrospective Chart Review of a Comprehensive Batten Clinic., PMID:38242022

Genetic Heterogeneity Underlying Phenotypes with Early-Onset Cerebellar Atrophy., PMID:38003592

Neuronal progenitor cells-based metabolomics study reveals dysregulated lipid metabolism and identifies putative biomarkers for CLN6 disease., PMID:37899458

Adult-onset Kufs disease., PMID:37802651

Genetic and sporadic forms of tauopathies-TAU as a disease driver for the majority of patients but the minority of tauopathies., PMID:37795931

Exome data of developmental and epileptic encephalopathy patients reveals de novo and inherited pathologic variants in epilepsy-associated genes., PMID:37353388

Characterization of neuropathology in ovine CLN5 and CLN6 neuronal ceroid lipofuscinoses (Batten disease)., PMID:37246363

Clinical and genetic characterization of neuronal ceroid lipofuscinoses (NCLs) in 29 Iranian patients: identification of 11 novel mutations., PMID:37074398

A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma., PMID:36858025

Sex-split analysis of pathology and motor-behavioral outcomes in a mouse model of CLN8-Batten disease reveals an increased disease burden and trajectory in female Cln8mnd mice., PMID:36369162

Lysosomal dysfunction, autophagic defects, and CLN5 accumulation underlie the pathogenesis of KCTD7-mutated neuronal ceroid lipofuscinoses., PMID:36368077

Weak evidence for a relation between bipolar disorder and heterozygous ZNF92 and CLN6 variants., PMID:36261122

Neuronal Ceroid Lipofuscinoses Presenting as Rett-like Phenotype: A Two-Case Report From Thailand., PMID:36137348

KCTD7 mutations impair the trafficking of lysosomal enzymes through CLN5 accumulation to cause neuronal ceroid lipofuscinoses., PMID:35921411

Heterozygosity for neuronal ceroid lipofuscinosis predisposes to bipolar disorder., PMID:35881528

Transmembrane Batten Disease Proteins Interact With a Shared Network of Vesicle Sorting Proteins, Impacting Their Synaptic Enrichment., PMID:35692423

Juvenile-Onset Kufs Disease in a Chinese Consanguineous Family due to CLN6 Mutation., PMID:35609511

Experimental Therapeutic Approaches for the Treatment of Retinal Pathology in Neuronal Ceroid Lipofuscinoses., PMID:35509995

Clinical and genetic characterization of a cohort of 97 CLN6 patients tested at a single center., PMID:35505348

Aggregation chimeras provide evidence of in vivo intercellular correction in ovine CLN6 neuronal ceroid lipofuscinosis (Batten disease)., PMID:35404973

Natural history of retinal degeneration in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses., PMID:35256654

Higher order visual dysfunction and myoclonic-atonic seizure: an atypical presentation of CLN6 neuronal ceroid lipofuscinosis., PMID:35140099

Neuronal Ceroid Lipofuscinosis Type 6 (CLN6) clinical findings and molecular diagnosis: Costa Rica's experience., PMID:35012600

A Novel CLN6 Variant Associated With Juvenile Neuronal Ceroid Lipofuscinosis in Patients With Absence of Visual Loss as a Presenting Feature., PMID:34868216

p.Asn77Lys homozygous CLN6 mutation in two unrelated Japanese patients with Kufs disease, an adult onset neuronal ceroid lipofuscinosis., PMID:34597687

[Clinical and genetic description of neuronal ceroid lipofuscinosis 6 type in the yakut family]., PMID:34481439

CLN6 deficiency causes selective changes in the lysosomal protein composition., PMID:34432360

Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS., PMID:34383793

CLN6's luminal tail-mediated functional interference between CLN6 mutants as a novel pathomechanism for the neuronal ceroid lipofuscinoses., PMID:34380921

Neuronal Ceroid Lipofuscinoses in Children., PMID:34220062

Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease., PMID:33930398

Pearls & Oy-sters: Levodopa-Responsive Adult NCL (Type B Kufs Disease) Due to CLN6 Mutation., PMID:33875558

Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes., PMID:33798445

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CLN6 Protein, N-GST & C-His [YHK83801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only